A prospective study for Safety and Tolerability of Once-Daily Bic/Ftc/Taf for Postexposure Prophylaxis
Latest Information Update: 03 Apr 2020
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Adverse reactions
Most Recent Events
- 03 Apr 2020 New trial record
- 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections